[1] 孟焕新.牙周病学[M]. 第4版.北京:人民卫生出版社, 2012: 12. [2] Wilson M, Reddi K, Henderson B. Cytokine-inducing components of periodontopathogenic bacteria [J]. J Periodont Res, 1996, 31(6): 393-407. [3] Taubman MA, Valverde P, Han X, et al. Immune response: the key to bone resorption in periodontal disease [J]. J Periodontol, 2005, 76(11 Suppl): 2033-2041. [4] Taubman MA, Kawai T. Involvement of T-lymphocytes in periodontal disease and in direct and indirect induction of bone resorption [J]. Crit Rev Oral Biol Med, 2001, 12(2): 125-135. [5] Rock KL, Latz E, Ontiveros F, et al. The sterile inflammatory response [J]. Annu Rev Immunol, 2010, 28: 321-342. [6] Souza PP, Brechter AB, Reis RI, et al. IL-4 and IL-13 inhibit IL-1β and TNF-α induced kinin BIL-4 and IL-13 inhibit IL-1β and TNF-α induced kinin B1 and B2 receptors through a STAT6-dependent mechanism [J]. Br J Pharmacol, 2013, 169(2): 400-412. [7] 黄煜, 李大金. 人早孕滋养细胞分泌趋化因子CXCL16促进自身增殖和侵袭 [J]. 分子细胞生物学报, 2006, 39(1): 15-21. [8] Zhang L, Ran L, Garcia GE, et a1. Chemokine CXCLI6 regulates neutrophil and macrophage infiltration into injured muscle, promoting muscle regeneration [J]. Am J Pathol, 2009, 175(6): 2518-2527. [9] Matloubian M, David A, Engel S, et a1. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo [J]. Nat Immuno1, 2000, 1(4): 298-304. [10] Wilbanks A, Zondlo SC, Murphy K, et a1. Expression cloning of the STRL33/BONZO/TYMSTR ligand reveals elements of CC, CXC, and CX3C chemokines [J]. J Immunol,200l,166(8):5145-5154. [11] Stricter RM, Burdick MD, Gomperts BN, et a1. CXC chemokines in angiogenesis [J]. Cytokine Growth Factor Rev, 2005, 16(6): 593-609. [12] Hosokawa Y, Nakanishi T, Yamaguchi D, et al. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in periodontal diseased tissue [J]. Clin Exp Immunol, 2005, 139(3): 506-512. [13] Hosokawa Y, Hosokawa I, Ozaki K, et al. CXCL12 and CXCR4 expression by human gingival fibroblasts in periodontal disease[J]. Clin Exp Immunol, 2005, 141(3): 467-474. [14] Hosokawa Y, Hosokawa I, Ozaki K, et al. Increase of CCL20 expression by human gingival fibroblasts upon stimulation with cytokines and bacterial endotoxin [J]. Clin Exp Immunol, 2005, 142(2): 285-291. [15] Schallhorn RA, Patel DN, Chandrasekar B, et al. Periodontal disease in association with systemic levels of interleukin-18 and CXC ligand 16 in patients undergoing cardiac catheterization [J]. J Periodontol, 2010, 81(8): 1180-1186. [16] Hosokawa Y, Hosokawa I, Ozaki K, et al. CXC chemokine ligand 16 in periodontal diseases: expression in diseased tissues and production by cytokine-stimulated human gingival fibroblasts [J]. Clin Exp Immumol, 2007, 149(1): 146-154. [17] Hosokawa Y, Hosokawa I, Ozaki K, et al. Human gingival fibroblasts express functional chemokine receptor CXCR6 [J]. Clin Exp Immunol, 2010, 156(3): 413-418. [18] 孙琳. Raf/MEK/ERK信号通路对CXCL16诱导的CIA淋巴细胞增殖的影响[J]. 军医进修学院学报,2010, 31(11): 1113-1115. [19] 司京玉, 聂生东, 陈瑛, 等. 免疫组织化学显微图像分析技术进展 [J]. 国际生物医学工程杂志, 2002, 25(3): 117-121. [20] Shimaoka T, Nakayama T, Fukumoto N, et al. Cell surface-anchored SR-PSOX/C-XC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor6 expressing cells [J]. J Leukoc Biol, 2004, 75(2): 267-274. [21] 刘芳. CXCL16/CXCR6与炎症性疾病 [J]. 国际病理科学与临床杂志, 2010, 10(30): 426-430. [22] Shimaoka T, Nakayama T, Kume N, et al. Cutting edge: SR-PSOX/CXC chemokine ligand 16 mediates bacterial phagocytosis by APCs through its chemokine domain[J]. J Immunol,2003,171(4): 1647-1651. [23] Manabe S, Iwase A, Goto M, et al. Expression and localization of CXCL16 and CXCR6 in ovarian endometriotic tissues [J]. Arch Gynecol Obstet, 2011,284(6): 1567-1572. [24] Gaida MM, Giinther F, Wagner C, et a1. Expression of the CXCR6 Oil polymerphonuclear neutrophils in pancreatic carcinoma and in acute, localized bacterial infections [J]. Clin Exp Immunol, 2008, 154(2): 216-223. [25] Hase K, Murakami T, Takatsu H, et a1. The membrane-bound chemokine CXCL16 expressed on follicle-associated epithelium and M cells mediates lympho-epithelial interaction in GALT [J]. J Immunol, 2006, 176(1): 43-51. [26] Ainola M, Mandelin J, Liljeström M, et a1. Imbalanced expression of RANKL and osteoprotegerin mRNA in pannus tissue of rheumatoid arthritis[J]. Clin Exp Rheumatol,2008,26(2): 240-246. [27] Isozaki T, Arbab AS, Haas CS, et al. Evidence that CXCL16 is a potent mediator of angiogenesis and is involved in endothelial progenitor cell chemotaxis: studies in mice with K/BxN serum-induced arthritis [J]. Arthritis Rheum, 2013, 65(7): 1736-1746. [28] Yamauchi R, Tanaka M, Kume N, et a1. Upregulation of SR-PSOX/CXCL16 and recruitment of CD8 T cells in cardiac valves during inflammatory valvular heart disease[J]. Arterioscler Thromb Vase Biol, 2004, 24(2): 282-287. |